OCUL – ocular therapeutix, inc. (US:NASDAQ)
Stock Stats
News
Is It Too Late To Consider Ocular Therapeutix (OCUL) After Recent Share Price Volatility? [Yahoo! Finance]
Ocular Therapeutix (NASDAQ:OCUL) Surprises With Q3 CY2025 Sales [Yahoo! Finance]
BofA Bullish on Ocular Therapeutix (OCUL) as AXPAXLI Targets Superiority Label and Faster Regulatory Path in Wet AMD [Yahoo! Finance]
Ocular Therapeutix (NASDAQ:OCUL) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $21.00 price target on the stock.
Ocular Therapeutix (NASDAQ:OCUL) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $20.00 price target on the stock.
Form 4 OCULAR THERAPEUTIX, INC For: Jan 02 Filed by: Anderman Todd
Form 4 OCULAR THERAPEUTIX, INC For: Jan 02 Filed by: Meyers Steve Lawrence
Form 4 OCULAR THERAPEUTIX, INC For: Jan 02 Filed by: Nayak Sanjay
Form 4 OCULAR THERAPEUTIX, INC For: Jan 02 Filed by: Kaiser Peter
Form 4 OCULAR THERAPEUTIX, INC For: Jan 02 Filed by: Saroj Namrata
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.